2019
DOI: 10.21873/invivo.11766
|View full text |Cite
|
Sign up to set email alerts
|

Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy

Abstract: Background: Low-grade fibromyxoid sarcoma (LGFMS) is a rare sarcoma subtype with a generally indolent pattern of clinical behaviour, but treatments for advanced disease are limited. Patients and Methods: A retrospective search of a prospectively maintained institutional database identified 102 patients treated from December 1994 to August 2018. We evaluated the outcome of patients and the efficacy and safety of non-surgical therapies in LGFMS. Results: Ninety-four out of 102 (92.2%) underwent primary resection… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(39 citation statements)
references
References 23 publications
1
36
0
Order By: Relevance
“…The genes CREB3L2 and CREB3L1 play a critical role in codifying transcription factors and contributing to the pathogenesis of the disease. In a study of 14 patients diagnosed with LGFMS, Cesne et al found no association between Complex 1 and the metastatic or recurrent potential of the tumor [ 11 13 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The genes CREB3L2 and CREB3L1 play a critical role in codifying transcription factors and contributing to the pathogenesis of the disease. In a study of 14 patients diagnosed with LGFMS, Cesne et al found no association between Complex 1 and the metastatic or recurrent potential of the tumor [ 11 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 20-25% of all sarcomas show some forms of chromosomal translocations. The majority of LGFMSs have a recurrent balanced translocation between chromosomes 7 and 16, involving the long arm (q) of chromosomes 32-34 and the short arms (p) 11, [11][12][13].…”
Section: Discussionmentioning
confidence: 99%
“…Chamberlain et al recently described their experience with non-surgical therapies to treat LGFMS. According to the authors, systemic therapy has limited efficacy in advanced LGFMS 7 . Unlu et al , reported two cases of paratesticular LGFMS treated with simple orchiectomy.…”
Section: Discussionmentioning
confidence: 99%
“…Despite its deceptively indolent clinical behavior and benign histological appearance, LGFMS has a high tendency for local recurrence and late distant metastasis 6 . The current treatment includes surgical excision with clear margins for localized disease with or without radiotherapy, while conventional systemic therapy has limited efficacy in advanced LGFMS 7 .…”
Section: Introductionmentioning
confidence: 99%
“…However, local recurrence can occur once or more after surgery, and the tumor can be even transferred to the lung for some patients. For patients with metastasis, surgical resection of the tumor is still the most effective method [4] , while radiotherapy and chemotherapy have no obvious bene ts in reducing the recurrence, metastasis and prolonging the survival time of LGFMS patients [7] . In a case series of 36 patients with LGFMS treated with surgical resection with curative intent, 5-and 15-year local control rates were 83% and 79%, respectively [5] .…”
Section: Discussionmentioning
confidence: 99%